¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦24Â÷ ´ëÇѳúÀüÁõÇÐȸ ±¹Á¦Çмú´ëȸ DAY2 : 2019-06-15

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
 Á¦24Â÷ ´ëÇѳúÀüÁõÇÐȸ ±¹Á¦Çмú´ëȸ DAY2 : 2019-06-15
±³À°ÀÏÀÚ : 2019-06-15
±³À°Àå¼Ò : ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2  
±³À°ÁÖÁ¦ : Á¦24Â÷ ´ëÇѳúÀüÁõÇÐȸ ±¹Á¦Çмú´ëȸ DAY2
ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѳúÀüÁõÇÐȸ  
´ã´çÀÚ : ±è¼Ò¿¬
¿¬¶ôó : 02-362-9662  
À̸ÞÀÏ : epilepsy@kes.or.kr      
±³À°Á¾·ù : ½Å°æ°ú      
Âü¼®¿¹»óÀοø : 350¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 200,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 08:00~08:20 Usual and unusual semiology  ±èÅÂÁØ(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 08:20~08:40 Psychogenic non-epileptic seizures  È²°æÁø(°æÈñÀÇ´ë) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 08:40~09:00 Other seizure mimicking cases  ±èÁö¿¬(°í·ÁÀÇ´ë) 
È޽Ġ06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ·Îºñ 09:00~09:10 Break  () 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 09:10~09:35 Renaming epilepsy in Korea: Does it improve stigma-related outcomes?  ÇѼöÇö(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 09:35~10:00 Institutional stigma in Korea  ·ùÇÑ¿í(ÀüºÏÀÇ´ë) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 10:00~10:25 Driving to distraction-certification of fitness to drive with epilepsy  John Dunne(Royal Perth Hospital, Australia) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 10:25~10:50 Genetic testing on patients with epilepsy  ÀÌÁöÈÆ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 10:50~11:15 Psychological support for family with intractable epilepsy  ¾ö¼Ò¿ë(¿¬¼¼ÀÇ´ë) 
Åä·Ð 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 11:15~11:20 Discussion  () 
È޽Ġ06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ·Îºñ 11:20~11:30 Coffee Break  () 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 11:30~11:50 Cognition and dementia in older patients with epilepsy  ¼­Á¾±Ù(°æºÏÀÇ´ë) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 11:50~12:10 Headache in patients with epilepsy  Áֹΰæ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 12:10~12:30 Mood disorder in patients with epilepsy  È«½ÂºÀ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 12:30~12:50 Sleep disorders in patients with epilepsy  Áö±âȯ(ÀÎÁ¦ÀÇ´ë) 
È޽Ġ06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ·Îºñ 12:50~13:00 Break  () 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 14:00~14:12 Progression of Cerebellar atrophy in anti-NMDA encephalitis and associated clinical parameters  ÀÌ¿ìÁø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 14:12~14:24 Gut microbiome in anti-NMDA receptor encephalitis  ÀÌÇÑ»ó(±«»ê±ºº¸°Ç¼Ò) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 14:24~14:36 Gut microbiome change in prolonged febrile seizure induction  ½Å¿ë¿ø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 14:36~14:48 Clinical outcome of Japanese encephalitis after treatment with ribavirin and interferon-¥á  ¼ÕÈ¿½Å(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 14:48~15:00 Perampanel therapeutic drug monitoring with saliva: correlation with plasma concentrations  ±èµµ¿ë(¼­¿ïÀÇ´ë) 
È޽Ġ06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ·Îºñ 15:00~15:10 Coffee Break  () 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 15:10~15:30 Definition of NORSE, FIRES, and related conditions  ÀüÁø¼±(°æºÏÀÇ´ë) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 15:30~15:50 Autoimmune encephalitis & status epilepticus  ¾çÅ¿ø(°æ»óÀÇ´ë) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 15:50~16:10 Treatment of refractory status epilepticus in children  ¹Ú¼Ò¿µ(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 16:10~16:30 Other treatment options for status epilepticus: ketogenic diet, hypothermia, surgery, etc.  ÀÌÁ¤È­(ÀÌÈ­ÀÇ´ë) 
È޽Ġ06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ·Îºñ 16:30~16:40 Break  () 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 16:40~17:00 Surgical treatment for epilepsy: the potential gap between evidence and practice  ±èÁ¾Çö(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 17:00~17:20 Laser interstitial thermal therapy for epilepsy  Ki Hyeong Lee(Epilepsy Center at Florida Hospital for Children, USA) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 17:20~17:40 Utilization of focused ultrasound for treatment of brain lesions  Àå¿ø¼®(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 06-15 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎ 1+2 17:40~18:00 Application of gamma knife radiosurgery for epilepsy  È«¼®È£(¿ï»êÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦24Â÷ ´ëÇѳúÀüÁõÇÐȸ ±¹Á¦Çмú´ëȸ DAY2 : 2019-06-15""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ´ç´¢º´ÇÐȸ °­¿øÁöȸ EGDM 2019 (Essential Guideline to Diabetes Management) : 2019-06-15
´ÙÀ½±Û ¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦29Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° : 2019-06-15
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 49 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 43 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 39 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 52 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 38 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 76 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 28 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 41 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 38 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 45 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 44 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 32 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 36 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 41 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 45 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷